António Costa consider the Bial a development model based on innovation – the guardian

The prime minister said today that the country must assume a model of development based on innovation, to preside over the signing of a contract in the amount of 37.4 million euros for research with the Bial.

the Story of Ruth Fonseca

“This investment by Bial is particularly relevant to the model that the country has definitely assume, that it is the development based on innovation”, stated António Costa, in Trofa, Porto, portugal.

The analogues of the Portuguese Bial and the Portuguese State signed an investment contract in the amount of 37.4 million to scientific research in the areas of systems, central nervous and cardiovascular.

This contract extends until 2018, and comes in the wake of the Government approved tax benefits for industrial investments approved in Council of Ministers last December.

“This story demonstrates well how a change of paradigm in the pharmaceutical industry is essential for the success it has today. For decades the industry was in research, not in the production of knowledge, not in innovation, not in the creation of patents, but in the counterfeiting of patents, was an illusion that was built on the future, fortunately, that paradigm was abandoned and today the following is another paradigm”, said the prime minister.

According to António Costa, one of the companies that prosper and have success is to Bial, which invests in research, in innovation and in the ability of transforming knowledge into economic value”.

“we are Not here to invest so that the statistics of exports from 2017 to register an increase in exports, we are here to invest so that in 15, 20 years we may have a new product that would increase the capacity to produce and the ability to export,” he explained.

“this Is why an investment in the medium/long term, where it is absolutely essential to the alignment of public policies and what is private investment,” he said.

The contract of 37 million euros with the BIAl will be applied in research in the areas of systems, central nervous and cardiovascular.